Who invested in Phoenix Molecular Designs?
One investor is on record as having backed Phoenix Molecular Designs — First-in-class RSK kinase inhibitors for cancer, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
phoenixmd.caPhoenix Molecular Designs investors
No round dates are on record for Phoenix Molecular Designs. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Phoenix Molecular Designs are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.